Dormant
ACIW · ACI Worldwide, Inc.
Last analysed ·
Resolved Graded and closed 2026-08-07 at medium conviction — the published kill line fired. Coverage continued after the close; the read below is dated 2026-09-13 and is not part of the scored record.
Current thesis
Special-situation breakup narrative accelerating: Reuters (2026-07-17) reports ACI exploring a ~$1.5B sale of its Biller unit, which would surface sum-of-the-parts value and re-rate the faster-growing Payments Software segment. Q1 beat + raised FY guide and a fresh DA Davidson PT bump to $64 confirm; Q2 print ~early August is the binary overlay.
Kill line
A weekly close below $54 surrenders the divestiture-rumor breakout shelf and flags the biller-sale bid fading; a company statement that the strategic review ended with no transaction would reinforce the break.
Pick status
Invalidated resolved published kill line fired How this is scored →Latest analysis and events for ACIW —
As of 13 September 2026, the latest FrontierPicks analysis for ACI Worldwide, Inc. (ACIW): Special-situation breakup narrative accelerating: Reuters (2026-07-17) reports ACI exploring a ~$1.5B sale of its Biller unit, which would surface sum-of-the-parts value and re-rate the faster-growing Payments Software segment. Q1 beat + raised FY guide and a fresh DA Davidson PT bump to $64 confirm; Q2 print ~early August is the binary overlay.
Kill line: A weekly close below $54 surrenders the divestiture-rumor breakout shelf and flags the biller-sale bid fading; a company statement that the strategic review ended with no transaction would reinforce the break.
Most recent dated event on file: — catalyst 5d ago.
Current Thesis
ACI Worldwide's payments-modernization recovery case requires a weekly reclaim of the former $54 breakout shelf while its raised 2026 revenue guidance survives; a daily close below $51.57 would break that case. The 2026-09-11 adjusted close of $52.09 remains below that former shelf and below the 2026-09-04 close of $52.95. The original divestiture-breakout thesis has already failed its published $54 condition; this narrower recovery case does not reverse that result.
As an inference, the narrative is maturing — the Cranium acquisition agreement dated 2026-09-01 extends the modernization story, but the 2026-09-11 close shows no recovery of the former breakout. ACI's release index, checked on 2026-09-13, still lists the Cranium announcement as its latest release; it supplies no subsequent transaction announcement. ACI release archive
Bullish and bearish views on ACI Worldwide, Inc.
The model's bull view on ACI Worldwide, Inc. (ACIW), in brief: Software growth supports the recovery. Payment Software revenue reached $196 million in Q2 2026, growing 9% reported and 7% excluding currency effects. ACI raised its 2026 revenue outlook to $1.895–1.925 billion on 2026-08-06. Q2 results Cards modernization has a signed… The bear view: Payment Software recurring revenue grew 3% reported. Both cases follow in full.
Bull Case
- Software growth supports the recovery. Payment Software revenue reached $196 million in Q2 2026, growing 9% reported and 7% excluding currency effects. ACI raised its 2026 revenue outlook to $1.895–1.925 billion on 2026-08-06. Q2 results
- Cards modernization has a signed agreement. ACI announced the Cranium Ventures acquisition agreement on 2026-09-01, with its switching technology intended for Connetic for Cards. Management expects completion in Q3 2026; failure to complete within that quarter would invalidate the announced timing, although not establish cancellation. Acquisition announcement
Bear Case
- Payment Software recurring revenue grew 3% reported. These measures provide less support for broad acceleration than total segment revenue does. 2026-08-06 results
- Divestiture value remains media-sourced. Reuters reported preliminary discussions about a roughly $1.5 billion Biller sale on 2026-07-17, according to the previously published coverage. That reported valuation is neither agreed consideration nor proceeds available to ACI. The release archive checked on 2026-09-13 contains no subsequent Biller transaction announcement. ACI release archive
Setup & Price Structure
The measured update is weaker price confirmation: the 2026-09-11 reference close was $52.09, the three-month price change was positive 15.1%, and the shares stood 13.4% below the supplied 52-week high of $60.18. The price remains inside the historical $51.57–$53.66 band documented for 2026-08-11 through 2026-08-21. Those observations support describing an unresolved recovery, not declaring that a durable base has formed.
A weekly close above $54 would satisfy the price component of the recovery case. The $51.57 threshold comes from the market's 2026-08-20 close, rather than a newly estimated support level. The supplied observations do not establish whether that threshold was tested between the published dates.
Positioning evidence is dated: StockAnalysis figures reported on 2026-08-23 showed short interest of 5.74 million shares and 5.76% of float, compared with 4.74 million shares and 4.79% reported on 2026-08-12. This records an increase in reported short interest; the sample is too small to support a claim about persistent crowding or a squeeze. No refreshed moving average, retail-participation measure or insider-transaction evidence is available here.
Catalyst Calendar (next 30 days)
- 2026-09-30 — Cranium timing checkpoint. This is the quarter-end boundary of management's Q3 2026 completion expectation announced on 2026-09-01, not an announced closing appointment. A completion disclosure would resolve execution timing; passage without one would leave completion unverified. Acquisition announcement
- ~2026-11-05, est. Q3 results. This date remains an estimate in the prior published coverage, outside the next 30 days. The report matters because it tests the $417–427 million Q3 revenue guidance issued on 2026-08-06 and whether the raised annual outlook remains intact. Q2 guidance
Elapsed catalysts
- 2026-09-15 — FT Partners FinTech Conference. ACI confirms management participation in New York. The listing establishes an investor meeting, not a promised Biller disclosure; attendance alone cannot confirm the divestiture case. ACI event listing (passed 5d ago)
What Would Change Our Mind
Loss of the historical August floor would end the narrower recovery case: a daily close below $51.57 breaches the market's 2026-08-20 reference close. The forecast's success condition is a weekly close above the former $54 shelf with the raised 2026 revenue guidance still intact, before that downside condition fires.
Fundamentally, Q3 revenue below management's $417 million floor or a reduction of its $1.895–1.925 billion annual revenue range would undermine the operating argument. Both thresholds were published on 2026-08-06. Company guidance
Correlation Notes
This is a single-company recovery case anchored to the 2026-08-06 operating report and the 2026-09-01 acquisition agreement. No peer-return series or measured thematic correlation accompanies the 2026-09-11 price evidence, so a group-led recovery cannot be asserted. The Cranium announcement concerns card-switching software; it supplies no evidence that AI data-center spending drives ACI's revenue. Acquisition announcement
Notes
- Biller sale is media-sourced (Reuters 2026-07-17, unnamed sources) — no signed agreement, no disclosed structure and no disclosed timeline as of 2026-09-05.
- Cranium Ventures terms were not disclosed: no purchase price, no revenue contribution, so accretion cannot be quantified from public material.
- License-revenue timing makes ACI's quarterly revenue lumpy; the FY range is a firmer anchor than any single quarter's print.
- Q2 Biller segment EBITDA included a charge tied to a terminated partnership, distorting segment margin comparisons (Q2 call, 2026-08-06).
- Q3 2026 earnings date is unconfirmed; the 2026-05-07 and 2026-08-06 cadence points to roughly early November.
- Institutional ownership is reported above 100% of shares outstanding (105.3%, 2026-08-12), a share-lending artifact rather than a float figure.
Related · shared themes
DAVE
Dave Inc.
Dave Inc.'s growth-and-credit-quality recovery case is invalidated by the September 18, 2026 weekly close of $337.82 below its published $358 boundary. JPMorgan's September 15 initiation adds favorable coverage but does not reverse that outcome.
SEZL
Sezzle Inc.
Sezzle's profitable-growth recovery thesis requires a daily close above $129.87 before a weekly close below $114 invalidates it. The 2026-09-18 adjusted close of $116.55 lost the August shelf again, reversing the intermediate repair described on September 11.
APGE
Apogee Therapeutics, Inc.
Apogee Therapeutics’ $135.11-per-share cash-acquisition thesis resolved with AbbVie’s completion on 2026-09-03. The 2026-09-14 Form 15 advances administrative closure, leaving no unresolved APGE acquisition catalyst.
ATAI
AtaiBeckley Inc.
AtaiBeckley's Lilly acquisition thesis resolved with completion on 2026-09-11, ending the pending-merger case. Remaining contingent payments depend on disclosed clinical and regulatory milestones; Nasdaq suspended ATAI effective 2026-09-14.